Completed NA INTERVENTIONAL 2-arm NCT04429802

The Effect of Prucalopride (Resolor®) on Gastric Motor Function and Gastric Sensitivity

Sponsor: Universitaire Ziekenhuizen KU Leuven

Conditions Dyspepsia Gastrointestinal Motility Disorder

Updated 6 times since 2020 Last updated: Oct 25, 2021 Started: Sep 26, 2013 Primary completion: Jun 1, 2015 Completion: Oct 3, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04429802, this NA trial focuses on Dyspepsia and Gastrointestinal Motility Disorder and remains completed. Sponsored by Universitaire Ziekenhuizen KU Leuven, it has been updated 6 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Nov 2022 — Jul 2024 [monthly]

Completed NA
Nov 2021 — Nov 2022 [monthly]

Completed NA
Jan 2021 — Nov 2021 [monthly]

Completed NA

▶ Show 1 earlier version

Jul 2020 — Jan 2021 [monthly]

Completed NA

First recorded

Sep 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Universitaire Ziekenhuizen KU Leuven

Data source: Universitaire Ziekenhuizen KU Leuven

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.